<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        53-22-02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2002
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CONCOR COR
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BISOPROLOL FUMARATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Merck Healthcare KGaA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Merck Healthcare KGaA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 606]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALHAYA MEDICAL CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Merck Healthcare KGaA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">The active substance in Concor Cor is bisoprolol. Bisoprolol belongs to a group of medicines called beta-blockers. These medicines work by affecting the body`s response to some nerve impulses, especially in the heart. As a result, bisoprolol slows down the heart rate and makes the heart more efficient at pumping blood around the body.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Heart failure occurs when the heart muscle is weak and unable to pump enough blood to supply the body&#39;s needs. Concor Cor is used to treat stable chronic heart failure.</p><p dir="ltr">It is used in combination with other medicines suitable for this condition (such as ACE-inhibitors, diuretics, and heart glycosides).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Do not take Concor Cor</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Do not take Concor Cor if one of the following conditions applies to you:</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergy (hypersensitivity) to bisoprolol or to any of the other ingredients (see section 6 &lsquo;What Concor Cor contains&rsquo;)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe asthma</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe blood circulation problems in your limbs (such as Raynaud&rsquo;s syndrome), which may cause your fingers and toes to tingle or turn pale or blue</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; untreated pheochromocytoma, which is a rare tumor of the adrenal gland</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; metabolic acidosis, which is a condition when there is too much acid in the blood.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Do not take Concor Cor if you have one of the following heart problems:</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; acute heart failure</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; worsening heart failure requiring injection of medicines into a vein, that increase the force of contraction of the heart</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; slow heart rate</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low blood pressure</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; certain heart conditions causing a very slow heart rate or irregular heartbeat</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cardiogenic shock, which is an acute serious heart condition causing low blood pressure and circulatory failure.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Warnings and precautions</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you have any of the following conditions tell your doctor before taking Concor Cor; he or she may want to take special care (for example give additional treatment or perform more frequent checks):</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diabetes</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; strict fasting</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; certain heart diseases such as disturbances in heart rhythm, or severe chest pain at rest (Prinzmetal&rsquo;s angina)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; kidney or liver problems</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; less severe blood circulation problems in your limbs</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chronic lung disease or less severe asthma</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; history of a scaly skin rash (psoriasis)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tumor of the adrenal gland (pheochromocytoma)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thyroid disorder.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In addition, tell your doctor if you are going to have:</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; desensitization therapy (for example for the prevention of hay fever), because Concor Cor 2.5 may make it more likely that you experience an allergic reaction, or such reaction may be more severe</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; anesthesia (for example for surgery), because Concor Cor may influence how your body reacts to this situation.</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you have chronic lung disease or less severe asthma please inform your doctor immediately if you start to experience new difficulties in breathing, cough, wheezing after exercise, etc. when using Concor Cor.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Children and adolescents</strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Concor Cor is not recommended for use in children or adolescents.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Other medicines and Concor Cor</p><p dir="ltr">&nbsp;</p><p dir="ltr">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><u>Do not take the following medicines with Concor Cor without special advice from your doctor:</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; certain medicines used to treat irregular or abnormal heartbeat (Class I antiarrhythmic medicines such as quinidine, disopyramide, lidocaine, phenytoin; flecainide, propafenone)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; certain medicines used to treat high blood pressure, angina pectoris or irregular heartbeat (calcium antagonists such as verapamil and diltiazem)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; certain medicines used to treat high blood pressure such as clonidine, methyldopa, moxonodine, rilmenidine. However, <strong>do not stop taking these medicines</strong> without checking with your doctor first.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Check with your doctor before taking the following medicines with Concor Cor; your doctor may need to check your condition more frequently:</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; certain medicines used to treat high blood pressure or angina pectoris (dihydropyridine-type calcium antagonists such as felodipine and amlodipine)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; certain medicines used to treat irregular or abnormal heartbeat (Class III antiarrhythmic medicines such as amiodarone)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; beta-blockers applied locally (such as timolol eye drops for glaucoma treatment)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; certain medicines used to treat for example Alzheimer&rsquo;s disease or glaucoma (parasympathomimetic such as tacrine or carbachol) or medicines that are used to treat acute heart problems (sympathomimetics such as isoprenaline and dobutamine)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antidiabetic medicines including insulin</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; anesthetic agents (for example during surgery)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; digitalis, used to treat heart failure</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; non-steroidal anti-inflammatory medicines (NSAIDs) used to treat arthritis, pain or inflammation (for example ibuprofen or diclofenac)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any medicine, which can lower blood pressure as a desired or undesired effect such as antihypertensives, certain medicines for depression (tricyclic antidepressants such as&nbsp; imipramine or amitriptyline), certain medicines used to treat epilepsy or during anesthesia (barbiturates such as phenobarbital), or certain medicines to treat mental illness characterized by a loss of contact with reality (phenothiazines such as levomepromazine)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mefloquine, used for prevention or treatment of malaria</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; depression treatment medicines called monoamine oxidase inhibitors (except MAO-B inhibitors) such as moclobemide.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Pregnancy and breast-feeding</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Pregnancy</em></p><p dir="ltr">There is a risk that use of Concor Cor during pregnancy may harm the baby. If you are pregnant or planning to become pregnant, tell your doctor. He or she will decide whether you can take Concor Cor during pregnancy.</p><p dir="ltr"><em>Breast-feeding</em></p><p dir="ltr">It is not known whether bisoprolol passes into human breast milk. Therefore, breastfeeding is not recommended during therapy with Concor Cor.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Driving and using machines</p><p dir="ltr">&nbsp;</p><p dir="ltr">Your ability to drive or use machinery may be affected depending on how well you tolerate the medicine. Please be especially cautious at the start of treatment, when the dose is increased or the medication is changed, as well as in combination with alcohol.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p dir="ltr">Treatment with Concor Cor 2.5 requires regular monitoring by your doctor. This is particularly necessary at the start of treatment, during dose increase, and when you stop treatment.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Take the tablet with some water in the morning, with or without food. Do not crush or chew the tablet.</p><p dir="ltr">The scored tablets can be divided into two equal doses.</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">Treatment with Concor Cor is usually long-term.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Adults including the elderly</p><p dir="ltr">&nbsp;</p><p dir="ltr">Treatment with bisoprolol must be started at a low dose and increased gradually.</p><p dir="ltr">Your doctor will decide how to increase the dose, and this will normally be done in the following way:</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.25 mg bisoprolol once daily for one week</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.5 mg bisoprolol once daily for one week</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.75 mg bisoprolol once daily for one week</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 mg bisoprolol once daily for four weeks</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.5 mg bisoprolol once daily for four weeks</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 mg bisoprolol once daily for maintenance (on-going) therapy.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The maximum recommended daily dose is 10 mg bisoprolol.</p><p dir="ltr">Depending on how well you tolerate the medicine, your doctor may also decide to lengthen the time between dose increases. If your condition gets worse or you no longer tolerate the drug, it may be necessary to reduce the dose again or to interrupt treatment. In some patients a maintenance dose lower than 10&nbsp;mg bisoprolol may be sufficient.</p><p dir="ltr">Your doctor will tell you what to do.</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you have to stop treatment entirely, your doctor will usually advise you to reduce the dose gradually, as otherwise your condition may become worse.</p><p dir="ltr"><s>&nbsp;</s></p><p dir="ltr">If you take more Concor Cor than you should</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you have taken more Concor Cor tablets than you should, tell your doctor immediately. Your doctor will decide what measures are necessary.</p><p dir="ltr">Symptoms of an overdose may include slowed heart rate, severe difficulty in breathing feeling dizzy, or trembling (due to decreased blood sugar).</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">If you forget to take Concor Cor</p><p dir="ltr">&nbsp;</p><p dir="ltr">Do not take a double dose to make up for a forgotten dose. Take your usual dose the next morning.</p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr">If you stop taking Concor Cor</p><p dir="ltr">&nbsp;</p><p dir="ltr">Never stop taking Concor Cor unless on your doctor&rsquo;s advice. Otherwise your condition could become much worse.</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you have any further questions on the use of this product, ask your doctor or pharmacist.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p dir="ltr">&nbsp;</p><p dir="ltr">To prevent serious reactions, speak to a doctor immediately if a side effect is severe, occurred suddenly or gets worse rapidly.</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr">The most serious side effects are related to the heart function:</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; slowing of heart rate (may affect more than 1 in 10 people)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; worsening of heart failure (may affect up to 1 in 10 people)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; slow or irregular heartbeat (may affect up to 1 in 100 people)</p><p dir="ltr">If you feel dizzy or weak or have breathing difficulties, please contact your doctor as soon as possible.</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr">Further side effects are listed below according to how frequently they may occur:</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>Common</strong> (may affect up to 1 in 10 people):</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness, feeling weak, dizziness, headache</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling of coldness or numbness in hands or feet</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low blood pressure</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stomach or intestine problems such as nausea, vomiting, diarrhea, or constipation.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Uncommon</strong> (may affect up to 1 in 100 people):</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sleep disturbances</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; depression</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness when standing up</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; breathing problems in patients with asthma or chronic lung disease</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle weakness, muscle cramps.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Rare</strong> (may affect up to 1 in 1,000 people):</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hearing problems</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic runny nose</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced tear flow</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the liver which can cause yellowing of the skin or whites of the eyes</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; certain blood test results for liver function or fat levels differing from normal</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergy-like reactions such as itching, flush, rash. You should see your doctor straight away if &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you experience more severe allergic reactions, which may involve face, neck, tongue, mouth or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; throat swelling, or difficulty breathing.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; impaired erection</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nightmares, hallucinations</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fainting</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Very rare</strong> (may affect up to 1 in 10,000 people):</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irritation and redness of the eye (conjunctivitis)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hair loss</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; appearance or worsening of scaly skin rash (psoriasis); psoriasis-like rash.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date which is stated on the blister and the carton after EXP. The expiry date refers to the last date of that month.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&deg;C.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This medicine does not require any special storage conditions.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Concor Cor 2.5 mg film-coated tablets</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is bisoprolol fumarate. Each film-coated tablet contains 2.5&nbsp;mg.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are:</p><p dir="ltr">Tablet core: Silica, colloidal anhydrous; magnesium stearate; crospovidone; maize starch; microcrystalline cellulose; calcium hydrogen phosphate (anhydrous).</p><p dir="ltr">Film coating: dimethicone; macrogol 400; titanium dioxide (E171); Hypromellose.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Concor Cor 2.5 mg film-coated tablets are white and heart-shaped with a break-line on both sides.
Each pack contains 30 tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Marketing Authorization Holder</p><p dir="ltr">&nbsp;</p><p dir="ltr">Merck Healthcare KGaA,</p><p dir="ltr">Frankfurter Strasse 250,</p><p dir="ltr">64293 Darmstadt,</p><p dir="ltr">Germany</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Manufacturer </strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Merck Healthcare KGaA,</p><p dir="ltr">Frankfurter Strasse 250,</p><p dir="ltr">64293 Darmstadt,</p><p dir="ltr">Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 23 Nov 2020.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>&nbsp;</p><p>المادة الفعالة في كونكور كور 2.5 هي بيسوبرولول. بيسوبرولول ينتمي إلى مجموعة من الأدوية تسمى حاصرات بيتا. تعمل هذه الأدوية عن طريق التأثير على استجابة الجسم لبعض النبضات العصبية ، وخاصة في القلب. ونتيجة لذلك ، يبطئ بيسوبرولول معدل ضربات القلب ويجعل القلب أكثر كفاءة في ضخ الدم في جميع أنحاء الجسم.</p><p>&nbsp;</p><p>&nbsp;</p><p>يحدث قصور القلب عندما تكون عضلة القلب ضعيفة وغير قادرة على ضخ ما يكفي من الدم لتلبية احتياجات الجسم. يستخدم كونكور كور 2.5 ملغ لعلاج فشل القلب المزمن المستقر. يتم استخدامه مع أدوية أخرى مناسبة لهذا العرض (مثل مثبطات الإنزيم المحول للأنجيوتنسين ، ومدرات البول ، وجليكوسيدات القلب).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><u>لا تأخذ كونكور كور 2.5 ملغ إذا كان أحد الاعراض التالية تنطبق عليك:</u></p><p><u>&nbsp;</u></p><p>&bull; الحساسية (فرط الحساسية) للبيزوبرولول أو لأي من المكونات الأخرى (انظر القسم 6 &quot;ما يحتوي عليه كونكورور 2.5&quot;)<br />&bull; الربو الحاد<br />&bull; مشاكل حادة في الدورة الدموية في أطرافك (مثل متلازمة رينود) ، والتي قد تتسبب في ارتخاء أصابع اليدين وأصابع القدمين أو تحول لونها شاحب أو أزرق ورم القواتم غير المعالج ، وهو ورم نادر في الغدة الكظرية.<br />&bull; الحماض الأيضي ، وهي حاله عندما يكون هناك الكثير من الأحماض في الدم.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><u>لا تأخذ كونكور كور 2.5 إذا كان لديك واحدة من مشاكل القلب التالية:</u></p><p><u>&nbsp;</u></p><p>&bull; فشل القلب الحاد<br />&bull; تفاقم قصور القلب الذي يتطلب حقن الأدوية في الوريد ، مما يزيد من قوة تقلص القلب<br />&bull; معدل ضربات القلب البطيء</p><p>&bull; ضغط دم منخفض<br />&bull; أمراض القلب معينة تسبب معدل ضربات القلب بطيئا للغاية أو عدم انتظام ضربات القلب<br />&bull; صدمة قلبية ، وهي حالة حادة خطيرة في القلب تسبب انخفاض ضغط الدم وفشل الدورة الدموية</p><p>&nbsp;</p><p>&nbsp;</p><p>المحاذير والإحتياطات</p><p>&nbsp;</p><p>إذا كان لديك أي من الحالات التالية أخبر طبيبك قبل اتخاذ كونكور كور 2.5 ملغ ؛ قد يرغب في رعاية خاصة (على سبيل المثال إعطاء علاج إضافي أو إجراء فحوصات أكثر تكرارًا):</p><p>&nbsp;</p><p>&bull; داء السكري<br />&bull; صيام صارم<br />&bull; بعض أمراض القلب مثل الاضطرابات في إيقاع القلب ، أو ألم شديد في الصدر أثناء الراحة (ذبحة برينزميتال)<br />&bull; مشاكل في الكلى أو الكبد<br />&bull; مشاكل الدورة الدموية أقل حدة في أطرافك<br />&bull; أمراض الرئة المزمنة أو الربو أقل حدة<br />&bull; تاريخ طفح جلدي متقشر (الصدفية)<br />&bull; ورم الغدة الكظرية (ورم القواتم)<br />&bull; اضطراب الغدة الدرقية.</p><p>&nbsp;</p><p>بالإضافة إلى ذلك ، أخبر طبيبك إذا كان لديك:<br />&bull; علاج إزالة الحساسية (على سبيل المثال للوقاية من حمى القش) ، لأن كونكور كور 2.5 ملغ قد يزيد من تعرضك لرد فعل تحسسي ، أو قد يكون هذا التفاعل أكثر حدة<br />&bull; التخدير (على سبيل المثال لعملية جراحية) ، لأن كونكور كور 2.5 ملغ قد يؤثر على كيفية تفاعل جسمك مع هذا الموقف.</p><p>&nbsp;</p><p>&nbsp;</p><p>إذا كنت تعاني من مرض رئوي مزمن أو ربو أقل حدة ، فيرجى إبلاغ طبيبك على الفور إذا بدأت تواجه صعوبات جديدة في التنفس والسعال والصفير بعد التمرين ، وما إلى ذلك عند استخدام كونكور كور 2.5 ملغ.</p><p>&nbsp;</p><p>الأطفال والمراهقين</p><p>&nbsp;</p><p>كونكور كور 2.5 ملغ غير مستحسن للاستخدام في الأطفال أو المراهقين.</p><p>&nbsp;</p><p>أدوية أخرى وكونكور كور 2.5 ملغ</p><p>&nbsp;</p><p>أخبر طبيبك أو الصيدلي إذا كنت تتناول ، أو تناولت مؤخرا أو قد تتناول أي أدوية أخرى.</p><p>&nbsp;</p><p><u>لا تأخذ الأدوية التالية مع كونكور كور 2.5 ملغ دون نصيحة خاصة من طبيبك:</u></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية المستخدمة لعلاج عدم انتظام ضربات القلب أو غير طبيعية (الأدوية المضادة لاضطراب النظم من الفئة الأولى مثل الكينيدين ، ديسوبيراميد ، ليدوكائين ، الفينيتوين ؛ فليكاينيد ، بروبافينون)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية المستخدمة لعلاج ارتفاع ضغط الدم أو الذبحة الصدرية أو عدم انتظام ضربات القلب (مضادات الكالسيوم مثل فيراباميل وديلتيازيم)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية المستخدمة لعلاج ارتفاع ضغط الدم مثل الكلونيدين ، ميثيل دوبا ، موكسونودين ، ريلمينيدين. ومع ذلك ، لا تتوقف عن تناول هذه الأدوية دون استشارة طبيبك أولاً.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><u>استشر طبيبك قبل تناول الأدوية التالية مع كونكور كور 2.5 ملغ؛ قد يحتاج طبيبك إلى فحص حالتك بشكل متكرر</u>:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية المستخدمة لعلاج ارتفاع ضغط الدم أو الذبحة الصدرية (مضادات الكالسيوم من نوع ديهيدروبيريدين مثل فيلوديبين وأملوديبين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية المستخدمة لعلاج عدم انتظام ضربات القلب أو غير طبيعية (الأدوية المضادة لاضطراب النظم من الدرجة الثالثة مثل الأميودارون)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حاصرات بيتا المطبقة محليا (مثل قطرات العين تيمولول لعلاج الجلوكوما)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية المستخدمة لعلاج مرض الزهايمر أو الجلوكوما (محاكاة الوبائي مثل التاكرين أو الكارباكول) أو الأدوية التي تستخدم لعلاج مشاكل القلب الحادة (مثل المحاكيات الودية مثل الآيزوبرينالين والدوبوتامين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المضادة للسكري بما في ذلك الأنسولين</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عوامل التخدير (على سبيل المثال أثناء الجراحة)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الديجيتالس ، يستخدم لعلاج قصور القلب</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المضادة للالتهابات غير الستيرويدية (مضادات الالتهاب غير الستيروئيدية) المستخدمة لعلاج التهاب المفاصل أو الألم أو الالتهابات (على سبيل المثال الإيبوبروفين أو ديكلوفيناك)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أي دواء ، يمكن أن يخفض ضغط الدم كتأثير مرغوب أو غير مرغوب فيه مثل مضادات فرط ضغط الدم ، أو أدوية معينة للاكتئاب (مضادات الاكتئاب ثلاثية الحلقات مثل إيميبرامين أو أميتريبتيلين) ، أو بعض الأدوية المستخدمة لعلاج الصرع أو أثناء التخدير (الباربيتورات مثل الفينوباربيتال) بعض الأدوية لعلاج الأمراض العقلية التي تتميز بفقدان الاتصال مع الواقع (الفينوثيازين مثل ليفومبرومازين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميفلوكين ، يستخدم للوقاية أو لعلاج الملاريا</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية علاج الاكتئاب تسمى مثبطات أوكسيديز أحادي الأمين (باستثناء مثبطات MAO-B) مثل موكلوبميد.</p><p>&nbsp;</p><p>&nbsp;</p><p>الحمل والرضاعة الطبيعية</p><p>&nbsp;</p><p><u>الحمل</u><br />هناك خطر من أن استخدام كونكور كور 2.5 ملغ أثناء الحمل قد يؤذي الطفل. إذا كنت حاملا أو تخططي لتصبحي حاملا ، أخبر طبيبك. سيقرر هو أو هي ما إذا كان يمكنك تناول كونكور كور 2.5 ملغ أثناء الحمل.</p><p><br /><u>الرضاعة الطبيعية</u><br />من غير المعروف ما إذا كان بيسوبرولول ينتقل إلى حليب الأم البشري. لذلك ، لا ينصح بالرضاعة الطبيعية أثناء العلاج مع كونكور كور 2.5 ملغ</p><p>&nbsp;</p><p>القيادة واستخدام الآلات</p><p>قد تتأثر قدرتك على القيادة أو استخدام الآلات اعتمادًا على مدى تحملك للدواء. يرجى توخي الحذر بشكل خاص في بداية العلاج ، عند زيادة الجرعة أو تغيير الدواء ، وكذلك في تركيبة مع الكحول.</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دائما تأخذ هذا الدواء تماما كما أخبر طبيبك. استشر طبيبك أو الصيدلي إذا كنت غير متأكد. يتطلب العلاج باستخدام كونكور كور 2.5 ملغ مراقبة منتظمة من قبل طبيبك. هذا ضروري بشكل خاص في بداية العلاج ، أثناء زيادة الجرعة ، وعندما تتوقف عن العلاج.<br /><br />خذ الحبه مع بعض الماء في الصباح ، مع أو بدون طعام. لا تسحق أو تمضغ الحبه.<br />يمكن تقسيم الأقراص المسجلة إلى جرعتين متساويتين.<br /><br />العلاج باستخدام كونكور كور 2.5 ملغ عادة ما يكون طويل الأجل.</p><p>الكبار بما في ذلك كبار السن</p><p>يجب البدء في العلاج باستخدام بيسوبرولول بجرعة منخفضة وزيادة تدريجية.سيقرر طبيبك كيفية زيادة الجرعة ، وسيتم ذلك بالطريقة التالية:</p><p>&nbsp;</p><p>&bull; 1.25 ملغ بيسوبرولول مرة واحدة يوميًا لمدة أسبوع<br />&bull; 2.5 ملغ بيسوبرولول مرة واحدة يوميًا لمدة أسبوع<br />&bull; 3.75 ملغ بيسوبرولول مرة واحدة يوميًا لمدة أسبوع<br />&bull; 5 ملغ بيسوبرولول مرة واحدة يوميًا لمدة أربعة أسابيع<br />&bull; 7.5 ملغ بيسوبرولول مرة واحدة يوميًا لمدة أربعة أسابيع<br />&bull; 10 ملغ بيسوبرولول مرة واحدة يوميًا للحصول على علاج (مستمر).</p><p>&nbsp;</p><p>الجرعة اليومية الموصى بها هي 10 ملغ بيسوبرولول.<br />بناءً على مدى تحملك للدواء ، قد يقرر طبيبك أيضًا إطالة المدة بين زيادات الجرعة. إذا كانت حالتك أسوأ أو لم تعد تتحمل الدواء ، فقد يكون من الضروري تقليل الجرعة مرة أخرى أو مقاطعة العلاج. في بعض المرضى ، قد تكون جرعة الاستقرار كافية على الأقل من 10 ملغ بيسوبرولول.سيخبرك طبيبك بما يجب عليك فعله.<br /><br />إذا كان عليك التوقف عن العلاج بالكامل ، فسوف ينصح طبيبك عادة بتخفيض الجرعة تدريجياً ، وإلا فقد تصبح حالتك أسوأ.</p><p>&nbsp;</p><p>&nbsp;</p><p>إذا كنت اخذت جرعه &nbsp;أكثر مما يجب من &nbsp;كونكور كور 2.5 ملغ</p><p>إذا كنت قد تناولت أقراص كونكور كور 2.5 ملغ أكثر مما يجب ، أخبر طبيبك على الفور. سيقرر طبيبك التدابير اللازمة.<br />قد تشمل أعراض الجرعة الزائدة تباطؤ معدل ضربات القلب ، وصعوبة شديدة في التنفس والشعور بالدوار ، أو الارتعاش (بسبب انخفاض نسبة السكر في الدم).</p><p>&nbsp;</p><p>إذا نسيت أن تأخذ كونكور كور 2.5 ملغ</p><p>لا تأخذ جرعة مضاعفة لتعويض جرعة منسية. خذ الجرعة المعتادة في صباح اليوم التالي.</p><p>&nbsp;</p><p>إذا توقفت عن تناول كونكور كور 2.5 ملغ</p><p>لا تتوقف أبدًا عن تناول كونكور كور 2.5 ملغ إلا بناءً على نصيحة الطبيب. خلاف ذلك يمكن أن تصبح حالتك أسوأ بكثير.<br />إذا كانت لديك أي أسئلة أخرى حول استخدام هذا المنتج ، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية ، يمكن أن يسبب هذا الدواء آثارًا جانبية ، على الرغم من عدم حصول الجميع عليها.</p><p><br />لمنع ردود الفعل الخطيرة ، تحدث إلى الطبيب على الفور إذا كان التأثير الجانبي شديدًا أو حدث فجأة أو ازداد سوءًا بسرعة.</p><p>&nbsp;</p><p>ترتبط الآثار الجانبية الأكثر خطورة بوظيفة القلب:</p><p>&nbsp;</p><p>&bull; تباطؤ معدل ضربات القلب (قد يؤثر على أكثر من 1 من كل 10 أشخاص)<br />&bull; تفاقم قصور القلب (قد يؤثر على شخص واحد من بين كل 10 أشخاص)<br />&bull; نبضات بطيئة أو غير منتظمة (قد تؤثر على شخص واحد من بين كل 100 شخص)</p><p>&nbsp;</p><p>إذا كنت تشعر بالدوار أو الضعف ، أو كنت تعاني من صعوبات في التنفس ، يرجى الاتصال بطبيبك في أقرب وقت ممكن.</p><p>&nbsp;</p><p>الآثار الجانبية الأخرى مدرجة أدناه وفقًا لتكرار حدوثها:</p><p>&nbsp;</p><p>شائع (قد يؤثر على شخص واحد من كل 10 أشخاص):<br />&bull; التعب ، والشعور بالضعف ، والدوخة ، والصداع<br />&bull; الشعور بالبرد أو التنميل في اليدين أو القدمين<br />&bull; ضغط دم منخفض<br />&bull; مشاكل في المعدة أو الأمعاء مثل الغثيان أو القيء أو الإسهال أو الإمساك.</p><p>&nbsp;</p><p>غير مألوف (قد يؤثر على شخص واحد من بين كل 100 شخص):<br />&bull; اضطرابات النوم<br />&bull; كآبة<br />&bull; الدوخة عند الوقوف<br />&bull; مشاكل في التنفس عند مرضى الربو أو مرض الرئة المزمن<br />&bull; ضعف العضلات وتشنجات العضلات.</p><p>&nbsp;</p><p>نادر (قد يؤثر على شخص واحد من كل 1000 شخص):<br />&bull; مشاكل في السمع<br />&bull; حساسية سيلان الأنف<br />&bull; انخفاض تدفق المسيل للدموع<br />&bull; التهاب الكبد الذي يمكن أن يسبب اصفرار الجلد أو بياض العينين<br />&bull; نتائج فحص الدم معينة عن وظائف الكبد أو مستويات الدهون تختلف عن طبيعية<br />&bull; ردود الفعل الشبيهة بالحساسية مثل الحكة والاحمرار والطفح الجلدي, يجب أن ترى طبيبك على الفور إذا كنت تعاني من ردود فعل تحسسية أكثر حدة ، والتي قد تشمل تورم الوجه أو الرقبة أو اللسان أو الفم أو الحلق أو صعوبة التنفس.<br />&bull; ضعف الانتصاب<br />&bull; الكوابيس والهلوسة<br />&bull; الإغماء</p><p>&nbsp;</p><p>نادر جدًا (قد يؤثر على ما يصل إلى شخص واحد من كل 10000 شخص):<br />&bull; تهيج واحمرار العين (التهاب الملتحمة)<br />&bull; تساقط الشعر</p><p>&bull; ظهور أو تفاقم طفح جلدي متقشر (الصدفية) ؛ طفح جلدي يشبه الصدفية.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull;&nbsp;&nbsp;&nbsp;احفظ هذا الدواء بعيدًا عن مرأى ومدى وصول الأطفال<br />&bull; &nbsp;لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور في نفطة والكرتون بعد EXP. يشير تاريخ انتهاء الصلاحية إلى آخر تاريخ لذلك الشهر.<br />&bull; لا تخزن المستحضر في درجة حراره&nbsp; اعلى من 30 درجة مئوية.<br />&bull; هذا الدواء لا يتطلب أي ظروف تخزين خاصة.<br /><br />لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. هذه التدابير سوف تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; المادة الفعالة هي بيسوبرولول فومارات. كل قرص مغلف فيلم يحتوي على 2.5 ملغ.</p><p>&nbsp;</p><p>&bull; المكونات الأخرى هي:<br />&nbsp;قرص الأساسية: السيليكا ، اللامائية الغروية. ستيرات المغنيسيوم. كروسبفيدون. نشا الذرة؛ السليلوز الجريزوفولفين. فوسفات هيدروجين الكالسيوم (لا مائي).</p><p>غلاف القرص : دايميثيكون. ماكروغول 400 ؛ ثاني أكسيد التيتانيوم (E171) ؛ هيدروكسي بروبيل ميثيل سيللوز.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص مغلفة بالفيلم بحجم 2.5 ملغ من كونكورس كور بلون أبيض وشكل قلب مع خط فاصل على كلا الجانبين</p><p>&nbsp;</p><p>كل عبوة تحتوي على 30 حبة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>صاحب ترخيص التسويق<br /><br />ميرك هيلث كير كي جي اي<br />فرانكفورتر شتراسه 250<br />64293 دارمشتات<br />دارمشتات ، ألمانيا.<br /><br />الصانع<br /><br />ميرك هيلث كير كي جي اي<br />فرانكفورتر شتراسه 250<br />64293 دارمشتات<br />دارمشتات ، ألمانيا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم مراجعة النشره بتاريخ 23 نوفمبر 2020 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Concor Cor 2.5 mg film coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Concor 2.5 mg:
One film-coated tablet contains 2.5 mg bisoprolol fumarate
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet.
Concor Cor 2.5 mg is white, heart-shape, biconvex with a dividing score
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ACE inhibitors, and diuretics, and optionally cardiac glycosides (for additional information see section 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Standard treatment of CHF consists of an ACE inhibitor (or an angiotensin receptor blocker in case of intolerance to ACE inhibitors), a beta-blocker, diuretics, and when appropriate cardiac glycosides. Patients should be stable (without acute failure) when bisoprolol treatment is initiated.</p><p dir="ltr">&nbsp;</p><p dir="ltr">It is recommended that the treating physician should be experienced in the management of chronic heart failure.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Transient worsening of heart failure, hypotension, or bradycardia may occur during the titration period and thereafter.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Posology</u></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Titration phase</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">The treatment of stable chronic heart failure with bisoprolol requires a stepwise titration phase.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The treatment with bisoprolol is to be started with a gradual uptitration according to the following steps:</p><p dir="ltr">&nbsp;</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.25 mg once daily for 1 week, if well tolerated increase to</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.5 mg once daily for a further week, if well tolerated increase to</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.75 mg once daily for a further week, if well tolerated increase to</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 mg once daily for the 4 following weeks, if well tolerated increase to</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.5 mg once daily for the 4 following weeks, if well tolerated increase to</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 mg once daily for the maintenance therapy.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The maximum recommended dose is 10 mg once daily.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Close monitoring of vital signs (heart rate, blood pressure) and symptoms of worsening heart failure is recommended during the titration phase. Symptoms may already occur within the first day after initiating the therapy.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Treatment modification</em></p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">If the maximum recommended dose is not well tolerated, gradual dose reduction may be considered.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In case of transient worsening of heart failure, hypotension, or bradycardia reconsideration of the dosage of the concomitant medication is recommended. It may also be necessary to temporarily lower the dose of bisoprolol or to consider discontinuation.</p><p dir="ltr">The reintroduction and/or up titration of bisoprolol should always be considered when the patient becomes stable again.</p><p dir="ltr">If discontinuation is considered, gradual dose decrease is recommended, since abrupt withdrawal may lead to acute deterioration of the patient&rsquo;s condition.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Treatment of stable chronic heart failure with bisoprolol is generally a long-term treatment.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Patients with hepatic or renal impairment</em></p><p dir="ltr">There is no information regarding pharmacokinetics of bisoprolol in patients with chronic heart failure and with impaired hepatic or renal function. Uptitration of the dose in these populations should therefore be made with additional caution.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Older People</em></p><p dir="ltr">No dosage adjustment is required.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Paediatric population</em></p><p dir="ltr">There is no paediatric experience with bisoprolol, therefore its use cannot be recommended in paediatric patients.</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>Method of administration </u></p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol tablets should be taken in the morning and can be taken with food. They should be swallowed with liquid and should not be chewed.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bisoprolol is contraindicated in chronic heart failure patients with:

•	acute heart failure or during episodes of heart failure decompensation requiring i.v. inotropic therapy
•	cardiogenic shock
•	second- or third-degree AV block 
•	sick sinus syndrome
•	sinoatrial block
•	symptomatic bradycardia 
•	symptomatic hypotension
•	severe bronchial asthma 
•	severe forms of peripheral arterial occlusive disease or severe forms of Raynaud's syndrome
•	untreated phaeochromocytoma (see section 4.4)
•	metabolic acidosis
•	hypersensitivity to bisoprolol or to any of the excipients listed in section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">&nbsp;</p><p dir="ltr">The treatment of stable chronic heart failure with bisoprolol has to be initiated with a special titration phase.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Especially in patients with ischemic heart disease the cessation of therapy with bisoprolol must not be done abruptly unless clearly indicated, because this may lead to transitional worsening of heart condition.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The initiation and cessation of treatment with bisoprolol necessitates regular monitoring.</p><p dir="ltr">&nbsp;</p><p dir="ltr">There is no therapeutic experience of bisoprolol treatment of heart failure in patients with the following diseases and conditions:</p><p dir="ltr">&nbsp;</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; insulin dependent diabetes mellitus (type I)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severely impaired renal function</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severely impaired hepatic function</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; restrictive cardiomyopathy</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; congenital heart disease</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; haemodynamically significant organic valvular disease</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; myocardial infarction within 3 months</p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol must be used with caution in:</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bronchospasm (bronchial asthma, obstructive airways diseases)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diabetes mellitus with large fluctuations in blood glucose values; Symptoms of hypoglycemia can be masked</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; strict fasting</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ongoing desensitisation therapy. As with other beta-blockers, bisoprolol may increase both the sensitivity towards allergens and the severity of anaphylactic reactions. Epinephrine treatment does not always yield the expected therapeutic effect.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; first degree AV block</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prinzmetal&rsquo;s angina; Cases of coronary vasospasm have been observed. Despite its high beta1-selectivity, angina attacks cannot be completely excluded when bisoprolol is administered to patients with Prinzmetal`s angina.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; peripheral arterial occlusive disease. Aggravation of symptoms may occur especially when starting therapy.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; general anaesthesia</p><p dir="ltr">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In patients undergoing general anesthesia beta-blockade reduces the incidence of arrhythmias and myocardial ischemia during induction and intubation, and the post-operative period. It is currently recommended that maintenance beta-blockade be continued peri-operatively. The anesthetist must be aware of beta-blockade because of the potential for interactions with other drugs, resulting in bradyarrhythmia&#39;s, attenuation of the reflex tachycardia and the decreased reflex ability to compensate for blood loss. If it is thought necessary to withdraw beta-blocker therapy before surgery, this should be done gradually and completed about 48 hours before anesthesia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Combination of bisoprolol with calcium antagonists of the verapamil or diltiazem type, with Class I antiarrhythmic drugs and with centrally acting antihypertensive drugs is generally not recommended, for details please refer to section 4.5.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Although cardio selective (beta1) beta-blockers may have less effect on lung function than nonselective beta-blockers, as with all beta-blockers, these should be avoided in patients with obstructive airways diseases, unless there are compelling clinical reasons for their use. Where such reasons exist, Emconcor CHF may be used with caution. The treatment of patients with obstructive diseases of the respiratory tract must be started with the lowest possible dose of bisoprolol and the patients must be monitored carefully regarding new symptoms, such as difficulty in breathing, stress intolerance and cough. In bronchial asthma or other chronic obstructive lung diseases, which may cause symptoms, bronchodilation therapy should be given concomitantly. Occasionally an increase of the airway resistance may occur in patients with asthma, therefore, the dose of beta2-stimulants may have to be increased.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Patients with psoriasis or with a history of psoriasis should only be given beta-blockers (e.g. bisoprolol) after carefully balancing the benefits against the risks.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In patients with pheochromocytoma bisoprolol must not be administered until after alpha-receptor blockade.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Under treatment with bisoprolol the symptoms of a thyrotoxicosis may be masked.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The use of Concor COR may lead to positive results in doping tests. The use of Concor COR for doping may be a threat for the user&rsquo;s health.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Combinations not recommended</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">Calcium antagonists of the verapamil type and to a lesser extent of the diltiazem type: Negative influence on contractility and atrio-ventricular conduction. Intravenous administration of verapamil in patients on &beta;-blocker treatment may lead to profound hypotension and atrioventricular block.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Class I antiarrhythmic drugs (e.g. quinidine, disopyramide; lidocaine, phenytoin; flecainide, propafenone): Effect on atrio-ventricular conduction time may be potentiated and negative inotropic effect increased.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Centrally acting antihypertensive drugs such as clonidine and others (e.g. methyldopa, moxonodine, rilmenidine): Concomitant use of centrally acting antihypertensive drugs may worsen heart failure by a decrease in the central sympathetic tonus (reduction of heart rate and cardiac output, vasodilation). Abrupt withdrawal, particularly if prior to beta-blocker discontinuation, may increase risk of &ldquo;rebound hypertension&rdquo;.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Combinations to be used with caution</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">Calcium antagonists of the dihydropyridine type such as felodipine and amlodipine: Concomitant use may increase the risk of hypotension, and an increase in the risk of a further deterioration of the ventricular pump function in patients with heart failure cannot be excluded.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Class-III antiarrhythmic drugs (e.g. amiodarone): Effect on atrio-ventricular conduction time may be potentiated.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Topical beta-blockers (e.g. eye drops for glaucoma treatment) may add to the systemic effects of bisoprolol.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Parasympathomimetic drugs: Concomitant use may increase atrio-ventricular conduction time and the risk of bradycardia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Insulin and oral antidiabetic drugs: Increase of blood sugar lowering effect. Blockade of beta adrenoreceptors may mask symptoms of hypoglycemia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Anesthetic agents: Attenuation of the reflex tachycardia and increase of the risk of hypotension (for further information on general anesthesia see also section 4.4.).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Digitalis glycosides: Reduction of heart rate, increase of atrio-ventricular conduction time.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Non-steroidal anti-inflammatory drugs (NSAIDs): NSAIDs may reduce the hypotensive effect of bisoprolol.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&beta;-Sympathomimetic agents (e.g. isoprenaline, dobutamine): Combination with bisoprolol may reduce the effect of both agents.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Sympathomimetics that activate both &beta;- and &alpha;-adrenoceptors (e.g. noradrenaline, adrenaline): Combination with bisoprolol may unmask the &alpha;-adrenoceptor-mediated vasoconstrictor effects of these agents leading to blood pressure increase and exacerbated intermittent claudication. Such interactions are considered to be more likely with nonselective &beta;-blockers.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Concomitant use with antihypertensive agents as well as with other drugs with blood pressure lowering potential (e.g. tricyclic antidepressants, barbiturates, phenothiazines) may increase the risk of hypotension.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Combinations to be considered</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">Mefloquine: increased risk of bradycardia</p><p dir="ltr">&nbsp;</p><p dir="ltr">Monoamine oxidase inhibitors (except MAO-B inhibitors): Enhanced hypotensive effect of the betablockers but also risk for hypertensive crisis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Pregnancy</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol has pharmacological effects that may cause harmful effects on pregnancy and/or the fetus/newborn. In general, beta-adrenoceptor blockers reduce placental perfusion, which has been associated with growth retardation, intrauterine death, abortion or early labour. Adverse effects (e.g. hypoglycemia and bradycardia) may occur in the fetus and newborn infant. If treatment with beta adrenoceptor blockers is necessary, beta<sub>1</sub>-selective adrenoceptor blockers are preferable.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol should not be used during pregnancy unless clearly necessary. If treatment with bisoprolol is considered necessary, the uteroplacental blood flow and the fetal growth should be monitored. In case of harmful effects on pregnancy or the fetus alternative treatment should be considered. The newborn infant must be closely monitored. Symptoms of hypoglycemia and bradycardia are generally to be expected within the first 3 days.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Breast-feeding</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">It is not known whether this drug is excreted in human milk. Therefore, breastfeeding is not recommended during administration of bisoprolol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">In a study with coronary heart disease patients bisoprolol did not impair driving performance. However, due to individual variations in reactions to the drug, the ability to drive a vehicle or to operate machinery may be impaired. This should be considered particularly at start of treatment and upon change of medication as well as in conjunction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The following definitions apply to the frequency terminology used hereafter:</p><p dir="ltr">&nbsp;</p><p dir="ltr">Very common (&ge; 1/10)</p><p dir="ltr">Common (&ge; 1/100 to, &lt; 1/10)</p><p dir="ltr">Uncommon (&ge; 1/1,000 to, &lt; 1/100)</p><p dir="ltr">Rare (&ge; 1/10,000 to, &lt; 1/1,000)</p><p dir="ltr">Very rare (&lt; 1/10,000)</p><p dir="ltr">Frequency not known (cannot be estimated from available data)</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Investigations:</u></p><p dir="ltr">Rare: increased triglycerides, increased liver enzymes (ALAT, ASAT).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Cardiac disorders:</u></p><p dir="ltr">Very common: bradycardia.</p><p dir="ltr">Common: worsening of heart failure.</p><p dir="ltr">Uncommon: AV-conduction disturbances.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Nervous system disorders:</u></p><p dir="ltr">Common: dizziness, headache.</p><p dir="ltr">Rare: syncope</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Eye disorders:</u></p><p dir="ltr">Rare: reduced tear flow (to be considered if the patient uses lenses).</p><p dir="ltr">Very rare: conjunctivitis.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Ear and labyrinth disorders:</u></p><p dir="ltr">Rare: hearing disorders.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Respiratory, thoracic and mediastinal disorders:</u></p><p dir="ltr">Uncommon: bronchospasm in patients with bronchial asthma or a history of obstructive airways disease.</p><p dir="ltr">Rare: allergic rhinitis.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Gastrointestinal disorders:</u></p><p dir="ltr">Common: gastrointestinal complaints such as nausea, vomiting, diarrhea, constipation.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Skin and subcutaneous tissue disorders:</u></p><p dir="ltr">Rare: hypersensitivity reactions (pruritus, flush, rash and angioedema).</p><p dir="ltr">Very rare: alopecia. Beta-blockers may provoke or worsen psoriasis or induce psoriasis-like rash.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Musculoskeletal and connective tissue disorders:</u></p><p dir="ltr">Uncommon: muscular weakness and cramps.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Vascular disorders:</u></p><p dir="ltr">Common: feeling of coldness or numbness in the extremities, hypotension.</p><p dir="ltr">Uncommon: orthostatic hypotension.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>General disorders:</u></p><p dir="ltr">Common: asthenia, fatigue.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Hepatobiliary disorders:</u></p><p dir="ltr">Rare: hepatitis.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Reproductive system and breast disorders:</u></p><p dir="ltr">Rare: erectile dysfunction.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Psychiatric disorders:</u></p><p dir="ltr">Uncommon: sleep disorder, depression.</p><p dir="ltr">Rare: nightmare, hallucination.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">To report any side effect(s):</p><ul dir="ltr"><li><strong><em>Saudi Arabia: </em></strong></li></ul><p dir="ltr">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" dir="ltr"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p><strong>- </strong>The National Pharmacovigilance Centre (NPC)</p><ul><li>Fax: +966-11-205-7662</li><li>Toll free phone: 19999</li><li>E-mail: npc.drug@sfda.gov.sa&nbsp;&nbsp;</li><li>Website: https://ade.sfda.gov.sa/</li></ul><p>&nbsp;</p></td></tr></tbody></table><p dir="ltr">&nbsp;</p><ul dir="ltr"><li>Other GCC States:</li></ul><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Symptoms</u></p><p dir="ltr">With overdose (e.g. daily dose of 15 mg instead of 7.5 mg) third degree AV-block, bradycardia, and dizziness have been reported. In general, the most common signs expected with overdosage of a betablocker are bradycardia, hypotension, bronchospasm, acute cardiac insufficiency and hypoglycemia. To date a few cases of overdose (maximum: 2000 mg) with bisoprolol have been reported in patients suffering from hypertension and/or coronary heart disease showing bradycardia and/or hypotension; all patients recovered. There is a wide interindividual variation in sensitivity to one single high dose of bisoprolol and patients with heart failure are probably very sensitive. Therefore, it is mandatory to initiate the treatment of these patients with a gradual up titration according to the scheme given in section 4.2.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Management</u></p><p dir="ltr">If overdose occurs, bisoprolol treatment should be stopped and supportive and symptomatic treatment should be provided. Limited data suggest that bisoprolol is hardly dialysable. Based on the expected pharmacologic actions and recommendations for other beta-blockers, the following general measures should be considered when clinically warranted.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Bradycardia: Administer intravenous atropine. If the response is inadequate, isoprenaline or another agent with positive chronotropic properties may be given cautiously. Under some circumstances, transvenous pacemaker insertion may be necessary.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Hypotension: Intravenous fluids and vasopressors should be administered. Intravenous glucagon may be useful.</p><p dir="ltr">&nbsp;</p><p dir="ltr">AV block (second or third degree): Patients should be carefully monitored and treated with isoprenaline infusion or transvenous cardiac pacemaker insertion.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Acute worsening of heart failure: Administer i.v. diuretics, inotropic agents, vasodilating agents.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Bronchospasm: Administer bronchodilator therapy such as isoprenaline, beta<sub>2</sub>-sympathomimetic drugs and/or aminophylline.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Hypoglycemia: Administer i.v. glucose.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Pharmacotherapeutic group: Beta blocking agents, selective</p><p dir="ltr">ATC Code: C07AB07</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>Mechanism of action</u></p><p dir="ltr">Bisoprolol is a highly beta<sub>1</sub>-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and relevant membrane stabilizing activity. Bisoprolol only shows low affinity to the beta<sub>2</sub>-receptor of the smooth muscles of bronchi and vessels as well as to the beta<sub>2</sub>-receptors concerned with metabolic regulation. Therefore, bisoprolol is generally not to be expected to influence the airway resistance and beta<sub>2</sub>- mediated metabolic effects. Its beta1-selectivity extends beyond the therapeutic dose range.</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>Clinical efficacy and safety</u></p><p dir="ltr">In total 2647 patients were included in the CIBIS II trial. 83% (n = 2202) were in NYHA class III and 17% (n = 445) were in NYHA class IV. They had stable symptomatic systolic heart failure (ejection fraction &lt;35%, based on echocardiography). Total mortality was reduced from 17.3% to 11.8% (relative reduction 34%). A decrease in sudden death (3.6% vs 6.3%, relative reduction 44%) and a reduced number of heart failure episodes requiring hospital admission (12% vs 17.6%, relative reduction 36%) was observed. Finally, a significant improvement of the functional status according to NYHA classification has been shown. During the initiation and titration of bisoprolol hospital admission due to bradycardia (0.53%), hypotension (0.23%), and acute decompensation (4.97%) were observed, but they were not more frequent than in the placebo-group (0%, 0.3% and 6.74%). The numbers of fatal and disabling strokes during the total study period were 20 in the bisoprolol group and 15 in the placebo group.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The CIBIS III trial investigated 1010 patients aged &sup3;65 years with mild to moderate chronic heart failure (CHF; NYHA class II or III) and left ventricular ejection fraction &pound;35%, who had not been treated previously with ACE inhibitors, beta-blockers, or angiotensin receptor blockers. Patients were treated with a combination of bisoprolol and enalapril for 6 to 24 months after an initial 6 months treatment with either bisoprolol or enalapril.</p><p dir="ltr">There was a trend toward higher frequency of chronic heart failure worsening when bisoprolol was used as the initial 6 months treatment. Non inferiority of bisoprolol-first versus enalapril-first treatment was not proven in the per-protocol analysis, although the two strategies for initiation of CHF treatment showed a similar rate of the primary combined endpoint death and hospitalization at study end (32.4% in the bisoprolol-first group vs. 33.1 % in the enalapril-first group, per-protocol population). The study shows that bisoprolol can also be used in elderly chronic heart failure patients with mild to moderate disease.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol is also used for the treatment of hypertension and coronary heart disease.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In acute administration in patients with coronary heart disease without chronic heart failure bisoprolol reduces the heart rate and stroke volume and thus the cardiac output and oxygen consumption. In chronic administration the initially elevated peripheral resistance decreases.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Absorption</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol is absorbed and has a biological availability of about 90% after oral administration.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Distribution</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">The distribution volume is 3.5 l/kg. The plasma protein binding of bisoprolol is about 30%.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Biotransformation and Elimination</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol is excreted from the body by two routes. 50% is metabolized by the liver to inactive metabolites which are then excreted by the kidneys. The remaining 50% is excreted by the kidneys in an unmetabolized form. Total clearance is approximately 15 l/h. The half-life in plasma of 10-12 hours gives a 24-hour effect after dosing once daily.</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>Linearity</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">The kinetics of bisoprolol are linear and independent of age.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Special population</u></p><p dir="ltr">Since the elimination takes place in the kidneys and the liver to the same extent a dosage adjustment is not required for patients with impaired liver function or renal insufficiency. The pharmacokinetics in patients with stable chronic heart failure and with impaired liver or renal function has not been studied. In patients with chronic heart failure (NYHA stage III) the plasma levels of bisoprolol are higher and the half-life is prolonged compared to healthy volunteers. Maximum plasma concentration at steady state is 64+21 ng/ml at a daily dose of 10 mg and the half-life is 17+5 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity or carcinogenicity. Like other beta-blockers, bisoprolol caused maternal (decreased food intake and decreased body weight) and embryo/fetal toxicity (increased incidence of resorptions, reduced birth weight of the offspring, retarded physical development) at high doses but was not teratogenic.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Concor COR 2.5&nbsp;mg</u></p><p dir="ltr">Tablet core:</p><p dir="ltr">Silica colloidal anhydrous 1.5 mg</p><p dir="ltr">magnesium (stearate, palmitate, oleate) 1.5 mg</p><p dir="ltr">crospovidone 5.5 mg</p><p dir="ltr">microcrystalline cellulose 10.0 mg</p><p dir="ltr">maize starch, 15.0 mg</p><p dir="ltr">calcium hydrogen phosphate. &nbsp;134.0 mg</p><p dir="ltr">&nbsp;</p><p dir="ltr">Film coating:</p><p dir="ltr">Dimethicone 0.11 mg</p><p dir="ltr">macrogol 400 (0.53 mg)</p><p dir="ltr">titanium dioxide 1.22 mg</p><p dir="ltr">Hypromellose 2.2 mg</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Shelf life for PVC/aluminum blister 
Concor COR 2.5 mg 
3 years.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Do not store above 30 &deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The container is a blister, which is made of a polyvinylchloride base film and an aluminum cover foil.</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">Folding box with push-through packs containing</p><p dir="ltr">30 film-coated tablets</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Merck Healthcare KGaA
Frankfurter Strasse 250
64293 Darmstadt
Darmstadt, Germany
Germany 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                23 Nov 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>